FDA Warning Letter — Zhejiang Huahai Pharmaceutical
The FDA took a Warning Letter action against Zhejiang Huahai Pharmaceutical on Nov 29, 2018 (Linhai, China). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Zhejiang Huahai Pharmaceutical
- Date
- Nov 29, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- Linhai (China)